Endocyte, Inc.

ENDOCYTE STRIVES FOR PRECISION IN MEDICINEAlthough great progress has been made in the development of new drugs to treat cancer and other serious illnesses, it is still difficult to predict if a patient will respond positively to existing therapies. In addition, therapies are often administered at suboptimal doses because of their effects on healthy tissues.Addressing these challenges through precision medicine has been our mission since the very beginning. Physicians aspire to treat patients with precision medicine, and Endocyte is committed to giving them the tools to do it.

Bank Name Endocyte, Inc.
Stock Exchange NASDAQ
Symbol ECYT
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region America
CEO Mr. Michael A. Sherman
Employees 44
Website www.endocyte.com
Registered Year 1995